Atlas FDA

GELSYN-3

FDA premarket approval P110005/S003 · decided 2018-05-07

Approval details

PMA number
P110005
Supplement
S003
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
GELSYN-3
Generic name
Acid, hyaluronic, intraarticular
Applicant
Ibsa Institut Biochimique SA
Date received
2018-04-09
Decision date
2018-05-07
Days to decision
28 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Lugano Ticino
Statement
Approval for a labeling change to the Product Information leaflet for GELSYN-3 for incorporation of additional details in the instructions for removal of the syringe cap, securing of the needle to the syringe, and removal of the needle shield in preparation for injection of the product.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.